Related Experiment Video

Updated: Jun 24, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke?

B Solun1, D Marcoviciu, D Dicker

  • 1Department of Internal Medicine A and D, Rabin Medical Center, Hasharon Hospital, Petah Tiqva, Israel.

European Journal of Internal Medicine
|March 31, 2009
PubMed

Insights

Hypertension affects one billion people globally. Treating high blood pressure, particularly with ACE inhibitors and AT1 receptor blockers, may prevent cardiac arrhythmias like atrial fibrillation and reduce stroke risk.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Hypertension is a prevalent global health issue affecting approximately one billion individuals.
  • Cardiac involvement is a significant complication of hypertension.
  • Atrial fibrillation is a common cardiac arrhythmia associated with hypertension.

Purpose of the Study:

  • To review cardiac involvement in hypertensive patients.
  • To evaluate the potential of antihypertensive treatments in preventing cardiac arrhythmias, specifically atrial fibrillation.
  • To explore the role of modern therapeutic approaches in managing hypertensive heart disease.

Main Methods:

  • Review of current literature on hypertension and cardiac complications.
  • Analysis of the electrical and structural remodeling processes in the hypertensive heart.
  • Comparison of different antihypertensive drug classes, including ACE inhibitors, AT1 receptor blockers, calcium channel blockers, beta-blockers, and thiazide-type diuretics.

Main Results:

  • Hypertension significantly impacts cardiac structure and function.
  • Electrical and structural remodeling in the hypertensive heart contributes to arrhythmia development.
  • ACE inhibitors and AT1 receptor blockers show promise in preventing atrial fibrillation compared to other drug classes.
  • Effective blood pressure management may reduce the incidence of stroke.

Conclusions:

  • Modern antihypertensive therapies, especially ACE inhibitors and AT1 receptor blockers, offer a more efficient option for managing hypertensive heart disease.
  • These agents may play a crucial role in preventing atrial fibrillation and reducing stroke incidence in hypertensive patients.
  • Targeting the remodeling process in the hypertensive heart is key to mitigating cardiac complications.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...